Predict your next investment

4Tech company logo
HEALTHCARE | Medical Devices & Equipment
4techtricuspid.com

See what CB Insights has to offer

Stage

Series B | Alive

Total Raised

$36M

Last Raised

$29M | 6 yrs ago

About 4Tech

4Tech is focused on the development of percutaneous solution for the treatment of Tricuspid valve disease. 4Tech TriCinch System for Transcatheter Tricuspid Valve Repair allows a simple and reproducible percutaneous procedure, designed to reduce TR and restore patient quality of life, while also allowing substantial potential cost-savings for the healthcare systems.

4Tech Headquarter Location

Business Park Unit 3

Galway,

Ireland

+35391380806

Latest 4Tech News

4Tech launches TriCinch coil system US feasibility study

Nov 2, 2018

MassDevice 4Tech launches TriCinch coil system US feasibility study November 2, 2018 4Tech  said that it launched an FDA-approved U.S.-based early feasibility study of its TriCinch coil system intended to reduce tricuspid regurgitation, The first two successful implantations of the device were performed at Atlanta’s Piedmont Heart Hospital by Dr. Christopher Meduri, Dr. Vivek Rajagopal and Dr. Mani Vannan, the Ireland-based company said. “We are pleased to be the first center in the U.S. to implant the TriCinch Coil System. Both procedures went smoothly, and the device was easy to implant. Having a technology like the TriCinch Coil System in our structural heart toolkit allows us to treat a wide range of patients suffering from tricuspid regurgitation, who are at high risk for open heart surgery, in a safe and simple manner,” Dr. Meduri said in a prepared statement. The TriCinch coil system is a percutaneous direct annuloplasty device designed to remodel the tricuspid valve through a nitinol coil anchor tensioned by a nitinol stent in the inferior vena cava. The system is currently being evaluated in a CE Mark trial seeking clearance in the European Union, with enrollment in Australia and Europe. “This is a major milestone for 4TECH, and I am excited with the progress the team has made. The TriCinch Coil System is designed to simply target the underlying pathology of annular dilatation. With this device, we are committed to helping patients who have very limited treatment options,” CEO Tom Fleming said in a press release. “Through our experience and in collaboration with key physicians, we have built a robust clinical program to evaluate the safety and efficacy of the device. I am encouraged by our momentum, and I am confident that we will provide physicians with a novel solution that will benefit patients suffering from TR,” CMO Dr. Keith Dawkins said in a prepared statement. In February, 4Tech said that it named a pair of  Boston Scientific  (NYSE: BSX ) veterans as its new CEO and CMO , with onetime chief Mike Ennen stepping away for “family reasons.” In case you missed it Stericycle (Nasdaq: SRCL) today posted third quarter earnings that topped Wall Street expectations for earnings per share but missed revenue consensus. The Lake Forest, Ill.-based company posted profits of $23.5 million, or 20¢ per share, on sales of $854.9 million for the three months ended September 30, seeing profits drop 39.7% while sales shrunk a smaller 3.2%… […] Gogoa Mobility Robots announced that it has received CE Mark approval for its Hank, lower limb exoskeleton system. Hank was designed to help rehabilitate adults who have suffered a neurological injury. The system can also be used for gait compensation in patients who have paralysis of the lower limbs after a spinal cord injury. The… […] The FDA recently cleared a pharmacogenetic DNA test from 23andMe that is designed to determine how users will react to certain pharmaceutical drugs. The FDA cleared the new 23andMe test to give information on 33 genetic variants that determine how patients will respond to more than 50 different prescribed and over-the-counter medications. The test, which… […] Stratasys (NSDQ:SSYS) shares jumped today after the 3D-printing giant beat the consensus with its third-quarter results. Minneapolis- and Rehovot, Israel-based Stratasys posted losses of -$679,000, or -1¢ per share, on sales of $162.0 million for the three months ended Sept. 30, paring its losses by -93.3% on sales growth of 4.0% compared with Q3 2017. Adjusted… […] Integer Holdings (NYSE:ITGR) share prices rose today after the contract manufacturer posted third-quarter results that handily beat the consensus forecast, powered by a whopping 733.3% bottom-line gain. Plano, Texas-based Integer reported profits of $114.1 million, or $3.54 per share, on sales of $305.1 million for the three months ended Sept. 28, for top-line growth of 6.6%… […] OsteoRemedies recently announced that it has received FDA clearance for its Remedy Spectrum GV hip spacer system and Spectrum GV bone cement. The system is designed to give surgeons a broad spectrum of treatment options with both Gentamicin and Vancomycin. Get the full story on our sister site, Drug Delivery Business. The post OsteoRemedies wins […] Arena Solutions recently announced that it has acquired Omnify Software (Andover, Mass.). The financial details of the deal were not disclosed. Omnify Software provides software to the electronics, medical devices, aerospace and defense and telecommunications markets. The cloud-based software that the company offers assists with new product development and new product introduction processes to reduce… […] Heraeus Medical Components said today that it acquired Evergreen Medical Technologies and its PhysioTest subsidiary for an undisclosed amount. St. Paul, Minn.-based Evergreen is a contract design, development & manufacturing consultant that specializes in neuromodulation technologies, including implantable leads and stimulation devices. “With over 600 diseases of the nervous system, neuromodulation will be an increasingly important… […] Syneo recently announced that it has redesigned and upgraded its Accu-Blast automated micro blasting equipment line. The company says it has increased the robustness and maintainability with the upgrade to the Accu-Blast CRS100. The system now features a Comco AccuFlo micro-abrasive blaster, newly designed Pinch Roll Feeders and in-line inspection option. It also includes an… […] Engineers at the University of California San Diego are using consumer fitness wearable technology and machine learning to predict blood pressure while offering personalized recommendations to lower it. Doctors can tell their patients to make lifestyle changes to lower blood pressure, but compliance is low, according to the researchers. “What if we could pinpoint the… […]

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing 4Tech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

4Tech is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

4Tech Patents

4Tech has filed 50 patents.

The 3 most popular patent topics include:

  • Cardiac anatomy
  • Cardiac surgery
  • Cardiology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/8/2019

9/14/2021

Annular solar eclipses, Cardiac surgery, Valvular heart disease, Cardiac anatomy, Cardiology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/8/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

9/14/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Annular solar eclipses, Cardiac surgery, Valvular heart disease, Cardiac anatomy, Cardiology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.